9 results
8-K
MLYS
Mineralys Therapeutics Inc
14 Jun 24
Departure of Directors or Certain Officers
8:06am
at Reata Pharmaceuticals. During the previous 11 years, he held multiple leadership positions at AstraZeneca, including the Executive Director
DEF 14A
MLYS
Mineralys Therapeutics Inc
9 Apr 24
Definitive proxy
7:15am
the vacancy. Mr. Congleton is currently a member of our board of directors.
All of our directors bring to the board of directors significant leadership … the Massachusetts Institute of Technology and an M.B.A. from Harvard Business School. Ms. Karydas’ extensive executive leadership and strategy experience
8-K
EX-99.1
MLYS
Mineralys Therapeutics Inc
21 Mar 24
Mineralys Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
7:43am
leadership, and scientific research. During her career, she has worked with biotech companies in the U.S. and overseas across broad therapeutic
8-K
EX-99
MLYS
Mineralys Therapeutics Inc
4 Jan 24
Mineralys Therapeutics Appoints Minji Kim, Ph.D. as Chief Business Officer
4:10pm
than two decades of experience in business development, strategic leadership, and scientific research. During her career, she has worked with biotech
8-K
EX-99.1
8ht4k63hzwq
7 Nov 23
Mineralys Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:07pm
DRS/A
bhhqlzkujmu6nt0k l3
29 Dec 22
Draft registration statement (amended)
12:00am
DRS/A
4i0g0j1hz ppsbbc
7 Dec 22
Draft registration statement (amended)
12:00am
DRS
rt7sa7 k3
4 Nov 22
Draft registration statement
12:00am
- Prev
- 1
- Next